Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis

Both radiolabelled choline and prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) could be used in patients with biochemical recurrent prostate cancer (BRPCa). We aimed to perform a meta-analysis about the head-to-head comparison of detection rate (DR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Nucl Med Mol Imaging
Hauptverfasser: Treglia, Giorgio, Pereira Mestre, Ricardo, Ferrari, Matteo, Bosetti, Davide G, Pascale, Mariarosa, Oikonomou, Eleni, De Dosso, Sara, Jermini, Fernando, Prior, John O, Roggero, Enrico, Giovanella, Luca
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526363/
https://ncbi.nlm.nih.gov/pubmed/31139496
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge